Funder: National Institutes of Health
Due Dates: August 6, 2025 (Letter of Intent) | September 5, 2025 (Application)
Funding Amounts: Up to $3,945,657 total costs (direct, indirect, fee) for up to 3 years; lower caps for some NIH Institutes (see below).
Summary: Supports small businesses with recent NIH SBIR/STTR Phase II/IIb awards to advance products to commercialization through technical assistance and late-stage R&D, requiring at least one clinical trial.
Key Information: Only U.S. small businesses with an active or recent (within 36 months) NIH SBIR/STTR Phase II/IIb award are eligible; clinical trial is required.